© Copyright 2025 American Medical Association. All rights reserved.
Hyperthermia generated by interstitial probe(s) is a specialized medical procedure aimed at elevating the temperature of tumor cells while minimizing damage to the surrounding healthy tissue. This technique utilizes interstitially placed applicators or probes that generate heat through various methods, including microwave, radiofrequency, or ultrasound energy. The fundamental principle behind this procedure is that tumor cells exhibit a higher sensitivity to increased temperatures compared to normal cells. By raising the temperature of the tumor cells, the procedure can enhance the efficacy of concurrent treatments such as radiation and chemotherapy, as well as potentially stimulate the immune system's components that contribute to the destruction of abnormal cells. Interstitial hyperthermia therapy is particularly beneficial for treating tumors located deep within the body, such as those found in the lungs or abdominal organs. During the procedure, the patient is placed under anesthesia, and the applicators or probes are carefully inserted into the tumor with the assistance of imaging techniques like x-ray or ultrasound guidance. Once positioned, a heat source is introduced into the applicators or probes, allowing the targeted area to be heated to a predetermined temperature. Following the treatment session, the probes are removed. The CPT® Code 77610 specifically reports interstitial hyperthermia therapy utilizing five or fewer interstitial applicators, while CPT® Code 77615 is designated for cases involving more than five applicators or probes.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure of hyperthermia generated by interstitial probe(s) is indicated for the treatment of various tumor types, particularly when they are located deep within the body. The following conditions may warrant the use of this procedure:
The procedure for hyperthermia generated by interstitial probe(s) involves several critical steps to ensure effective treatment. Each step is designed to maximize the therapeutic effects while minimizing risks to surrounding healthy tissue.
After the hyperthermia treatment, patients may require monitoring for any immediate side effects or complications. Common post-procedure care includes assessing the insertion sites for signs of infection or adverse reactions. Patients may experience localized discomfort or swelling, which can be managed with appropriate pain relief measures. Follow-up appointments are typically scheduled to evaluate the effectiveness of the treatment and to determine if additional sessions are necessary. It is essential for healthcare providers to provide patients with clear instructions regarding any activity restrictions or care requirements following the procedure to ensure optimal recovery and outcomes.
Short Descr | HYPERTHERMIA NTRSTL PRB 5/< | Medium Descr | HYPERTHERMIA INTERSTITIAL PROBE 5/< APPLICATORS | Long Descr | Hyperthermia generated by interstitial probe(s); 5 or fewer interstitial applicators | Status Code | Restricted Coverage | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 1 - Diagnostic Tests for Radiology Services | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Not Discounted when Multiple | ASC Payment Indicator | Radiology service paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS relative payment weight. | Type of Service (TOS) | 6 - Therapeutic Radiology | Berenson-Eggers TOS (BETOS) | P7B - Oncology - other | MUE | 1 | CCS Clinical Classification | 211 - Therapeutic radiology |
26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | GC | This service has been performed in part by a resident under the direction of a teaching physician |
Date
|
Action
|
Notes
|
---|---|---|
2025-01-01 | Changed | Short Description changed. |
2017-01-01 | Changed | Moderate (Conscious) Sedation flag removed. See new Moderate Sedation category. |
Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.